Amylyx Pharmaceuticals
Highly Engaged Employees
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
55 Cambridge Pkwy Ste 6W, Cambridge, Mas...Phone Number
(617) 682-0917Website
www.amylyx.comRevenue
-Stock Symbol
AMLXIndustry
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a novel therapeutic for Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease and other neurodegenerative diseases. The company's therapeutic, AMX0035, targets the neuroinflammation and nerve cell death that characterize these diseases. AMX0035 is a proprietary combination of existing compounds that act synergistically to prevent cell death and neurotoxic inflammation in multiple preclinical models.Explore more
SIC Code 28,283NAICS Code 54,541Ticker NASDAQ: AMLXShow moreAmylyx Pharmaceuticals Org Chart
Compare Similar Companies to Amylyx Pharmaceuticals
Compare insights from companies similar to Amylyx Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Amylyx Pharmaceuticals Tech Stack
A closer look at the technologies used by Amylyx Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amylyx Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a novel therapeutic for Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease and other neurodegenerative diseases. The company's therapeutic, AMX0035, targets the neuroinflammation and nerve cell death that characterize these diseases. AMX0035 is a proprietary co... Read More

